CEimpact Podcast

Sexually transmitted infection (STI) risk in high risk patients is a common problem compounded by antimicrobial resistance. Join host, Geoff Wall, with guest Amanda Bushman, as they discuss a new post-exposure prophylaxis (PEP) therapy for STI prevention
 
The GameChanger
Sexually transmitted infection incidence is higher than most clinicians suspect. Doxycycline may offer effective post-exposure prophylaxis for some HIV positive patients.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Amanda Bushman, PharmD, BCIDP
Clinical Pharmacist
UnityPoint Health

References
 Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934. PMID: 37018493; PMCID: PMC10140182.
 
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
 

CE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the DOXY-PEP study
2. Apply results of DOXY-PEP to patient care
 
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-205-H01-P
Initial release date: 5/22/2023
Expiration date: 5/22/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

While we all know students who may exhibit more confidence that they have the right to based on their actual knowledge and experience, more often as preceptors we have students who demonstrate a lack of confidence that gets in the way of their learning. It is easy to make assumptions about why a student demonstrates a lack of confidence, but often we have missed the mark. By understanding the root cause of waning confidence in a pharmacy learner, we can develop strategies to increase confidence and allow them to optimize their learning. 

Dr. Kate Newman, Director of Experiential Education, and Dr. Stephanie Hunziker, Director of Skills and Simulation and a Clinical Assistant Professor are both from Southern Illinois University Edwardsville School of Pharmacy. They have recognized the negative impact that low confidence can have on learner outcomes and have lots to share about challenges and strategies for identifying the root cause of low confidence, as well as teaching tactics and methods to overcome them.  

Host
Kathy Schott, PhD
CEimpact
 
Guests
Kate Newman, PharmD
Director of Experiential Education 
Clinical Associate Professor, Pharmacy Practice 
Southern Illinois University Edwardsville, School of Pharmacy 

Stephanie Hunziker, PharmD
Director of Skills and Simulation 
Clinical Assistant Professor 
Southern Illinois University Edwardsville School of Pharmacy  

CE Information 

At the end of this course, preceptors will be able to: 

1. Recognize potential reasons as learner may appear to lack confidence in a clinical setting. 
2. Discuss strategies to help students overcome barriers and increase confidence. 

This program has been: 

• Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors. 
• Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors. 

 
Want more information on this and related topics?  

True Grit: Developing a Philosophy of Failure 

Pharmacy learners are innately afraid to look silly, say the wrong thing, or make mistakes that could result in negative feedback. This fear can manifest in a perceived lack of confidence. This course provides pearls for creating an safe and supportive environment where failure isn’t something to be ashamed of, but rather a path to greater learning. 

Feedback is essential to developing a trusting and safe environment where learners can grow in their confidence. This course will give you some proven strategies for accepting and implementing critical

Follow CEimpact on Social Media:
LinkedIn
Instagram

About 50% of Americans have hypertension, yet WHICH is a preferred anti-hypertensive strategy is a random process. And pharmacogenomics may not be needed. Join host, Geoff Wall, as he evaluates a recent study evaluating the role of personalized medication selection for persons with hypertension.
 
The GameChanger
Although no genetic markers exist to determine optimal hypertensive pharmacotherapy, initial and secondary hypertensive therapy does impact outcomes. A personalized approach does produce a greater reduction in blood pressure.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
Sundström J, Lind L, Nowrouzi S, et al. Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial. JAMA. 2023;329(14):1160–1169. doi:10.1001/jama.2023.3322

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
 
 
CE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the results of the PHYSIC study
2. Discuss the limitations of the PHYSIC study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-205-H01-P
Initial release date: 5/22/2023
Expiration date: 5/22/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 2 of a two-part series examining new research on the proposed RSV vaccine.
 
The GameChanger
RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in pregnant patients may help newborns.
 
Show Segments
00:00 - Introductions
02:57 - Recap From Part 1
06:45 - Looking at the MATISSE Study
14:17 - The GameChanger: MATISSE Results
22:27 - Connecting to Practice: Barriers to Applying
31:05 - Closing Remarks
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

Reference
Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
 

CE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the MATISSE study in relation to RSV vaccines
2. Describe barriers to applying the information in this study to general populations

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-193-H06-P
Initial release date: 05/08/2023
Expiration date: 05/08/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 1 of a two-part series examining new research on the proposed RSV vaccine.

The GameChanger
RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in older adults improves antibody titers.

Show Segments
00:00 - Introductions
03:06 - Barriers to Development of the RSV Vaccine
06:46 - Looking at the RSV Vaccine Study
13:01 - The GameChanger: The Vaccine Outcomes
20:57 - Connecting to Practice: The Potential Future of This Vaccine
28:19 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005 Apr 28;352(17):1749-59. doi: 10.1056/NEJMoa043951. PMID: 15858184.


Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe barriers to development of an RSV vaccine
2. Discuss outcomes of an RSV vaccines in older adults

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-192-H06-P
Initial release date: 05/01/2023
Expiration date: 05/01/2024

Follow CEimpact on Social Media:
LinkedIn
Instagram

Community Acquired Pneumonia (CAP) has a high mortality rate. A new study evaluates the use of hydrocortisone for severe CAP in the ICU setting. Join host, Geoff Wall, as he evaluates if the evidence stacks up.

The GameChanger
The use of steroids to treat severe pneumonia has waxed and waned for many years with insufficient evidence. A recent study found steroids improved a number of outcomes, including mortality.

Show Segments
00:00 - Introductions
01:19 - Past Studies on CAP Treatment
03:32 - The CAPE Code Study
17:05 - The GameChanger: The Study Findings
24:31 - Connecting to Practice: Study Limitations
26:01 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Hydrocortisone in Severe Community-Acquired Pneumonia

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the past history of major mortality studies for CAP pharmacotherapy
2. Discuss the CAPE Code study and its possible implications in the ICU

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-147-H01-P
Initial release date: 04/24/2023
Expiration date: 04/24/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Co-precepting can help with workload while providing a diverse experience for learners, but it is not without its challenges. Listen in to weigh the pros and cons while gathering some strategies to ensure success if you plan to consider, or are currently, co-precepting with a colleague.

Kate Newman is the Director of Experiential Education at Southern Illinois University Edwardsville School of Pharmacy. She’s been seeing more co-precepting arrangements with her affiliate experiential education sites and has seen what works, and of course what doesn’t work. I asked her to share some tips and strategies with me that have helped ensure a good learning experience at sites where preceptors are sharing the teaching load. Listen in!

Host
Kathy Schott, PhD
CEimpact

Guests
Kate Newman, PharmD
Director of Experiential Education
Clinical Associate Professor, Pharmacy Practice
Southern Illinois University Edwardsville, School of Pharmacy

Get CE
Click here to access the course

CE Information

At the end of this course, preceptors will be able to:

1. Describe co-precepting and the pros and cons commonly associated with it.

2. Identify potential challenges and strategies to address them.

UAN: 0107-0000-23-149-H99-P
 Release Date: 04/19/2023
 Expiration Date: 04/19/2026
 The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

• Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
• Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

 Want more information on this and related topics? 

 Using Feedback to Improve Your Teaching 

Feedback may be more important than ever when working in a co-precepting environment – from students and from your fellow co-preceptors. This course will give you some proven strategies for accepting and implementing critical feedback on your teaching.

Tools to Facilitate Student Success with Your Learning Experience 

Preceptors often don’t feel they have time or know how to go about creating an appropriate amount of structure within the experiences they provide for student pharmacists. In this CPE course, preceptors have the opportunity to learn and apply simple quality improvement techniques to maintain and enhance their learning experience.

The Eleven Habits of Highly Effective Preceptors

Regardless of your precepting environment, there’s always room for self-assessment. This tool will allow you to assess your own strengths and areas for development as a preceptor so that you can develop your own professional development plan as a teacher and mentor.

 As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask you experiential program director if you are a member so that you can access it all for free!

Follow CEimpact on Social Media:
LinkedIn
Instagram

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

Several studies have found the improved outcomes and quality of life through deprescribing. However, it rarely happens. Join host, Geoff Wall, with guest, Kristin Meyer, as they evaluate a new studying looking at pharmacist-provided describing services during transition of care.

The GameChanger
Older patients are on numerous medications often with limited therapeutic benefit and high risk of adverse events. Many of these medications can be discontinued with no change in outcomes. Pharmacists are uniquely positioned to support deprescribing protocols.

Show Segments
00:00 - Introductions
01:46 - Arguments for Deprescribing
05:44 - Looking at the Study
16:32 - The GameChanger: Deprescribing Results
22:42 - Connecting to Practice: Dr. Meyer’s Thoughts on Results
31:08 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Kristin Meyer, PharmD, BCGP
Professor of Pharmacy Practice, Drake University

References and Resources

Vasilevskis EE, Shah AS, Hollingsworth EK, et al. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):223–231. doi:10.1001/jamainternmed.2022.6545

O'Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30. PMID: 31790317.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the importance and benefits of deprescribing medications in elderly patients
2. Discuss the assessment scoring systems used to assess deprescribing activities

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-146-H01-P
Initial release date: 04/17/2023
Expiration date: 04/17/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

ICU patients are at high risk for venous thromboembolism, and the majority of patients require prophylaxis. The challenging therapy is thrombocytopenia. Join host Geoff Wall, as he evaluates the results of a new study evaluating the clinical thresholds for chemical prophylaxis.

The GameChanger
The majority of ICU patients eligible for VTE prophylaxis do not receive it. Different clinicians use different thresholds to initiate or stop prophylaxis. The database study discussed provides a potential evidence-based threshold.

Show Segments
00:00 - Introductions
00:47 - VTE Prophylaxis Background
09:34 - Looking at the Study
18:42 - The GameChanger: A Potential Threshold for Chemical Prophylaxis
22:15 - Connecting to Practice: Applicability
26:13 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history and use of VTE prophylaxis in the ICU
2. Describe the results of the Pang et al study discussed and its applicability to ICU patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-134-H01-P
Initial release date: 04/10/2023
Expiration date: 04/10/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram